Cardiac magnetic resonance imaging in today's economic climate; a cost effectiveness analysis

The most savings were observed in pts who received a new diagnosis such as tumor not thrombus, sarcoid not ARVD or benign mass not cancer, and the least, in the routine follow up of clinically stable patients with vascular pathologies such as aneurysms, dissections or pulmonary vein imaging post abl...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular magnetic resonance Vol. 13; no. S1; p. M12
Main Authors Hegde, Vinayak A, Mikolich, J Ronald, Doyle, Mark, Rathi, Vikas K, Yamrozik, June A, Williams, Ronald B, Biederman, Robert
Format Journal Article
LanguageEnglish
Published New York BioMed Central 02.02.2011
BioMed Central Ltd
Elsevier
Subjects
Blood clots
Cost control
Hospitals
Moderated Poster Presentation
Online AccessGet full text

Cover

More Information
Summary:The most savings were observed in pts who received a new diagnosis such as tumor not thrombus, sarcoid not ARVD or benign mass not cancer, and the least, in the routine follow up of clinically stable patients with vascular pathologies such as aneurysms, dissections or pulmonary vein imaging post ablation for atrial fibrillation.
ISSN:1532-429X
1097-6647
1532-429X
DOI:10.1186/1532-429X-13-S1-M12